首页> 美国卫生研究院文献>other >The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double strand break repair and mismatch repair
【2h】

The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double strand break repair and mismatch repair

机译:MutSβ复合物通过其在DNA双链断裂修复和错配修复中的功能而成为p53驱动的肿瘤发生的调节剂。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Loss of the DNA mismatch repair protein MSH3 leads to the development of a variety of tumors in mice without significantly affecting survival rates, suggesting a modulating role for the MutSβ (MSH2-MSH3) complex in late onset tumorigenesis. To better study the role of MSH3 in tumor progression, we crossed Msh3−/− mice onto a tumor predisposing p53-deficient background. Survival of Msh3/p53 mice was not reduced compared to single p53 mutant mice; however, the tumor spectrum changed significantly from lymphoma to sarcoma, indicating MSH3 as a potent modulator of p53-driven tumorigenesis. Interestingly, Msh3−/− mouse embryonic fibroblasts displayed increased chromatid breaks and persistence of γH2AX foci following ionizing radiation, indicating a defect in DNA double strand break repair. Msh3/p53 tumors showed increased loss of heterozygosity, elevated genome-wide copy number variation, and a moderate microsatellite instability phenotype compared to Msh2/p53 tumors, revealing that MSH2-MSH3 suppresses tumorigenesis by maintaining chromosomal stability. Our results show that the MSH2-MSH3 complex is important for the suppression of late onset tumors due to its role in DNA double strand break repair as well as in DNA mismatch repair. Furthermore, they demonstrate that MSH2-MSH3 suppresses chromosomal instability and modulates the tumor spectrum in p53-deficient tumorigenesis, and possibly plays a role in other chromosomally unstable tumors as well.
机译:DNA错配修复蛋白MSH3的缺失导致小鼠中多种肿瘤的发生,而没有显着影响存活率,这提示MutSβ(MSH2-MSH3)复合物在晚期发病中起调节作用。为了更好地研究MSH3在肿瘤进展中的作用,我们将Msh3 -/-小鼠越过了具有p53缺陷背景的肿瘤。与单个p53突变小鼠相比,Msh3 / p53小鼠的存活率并未降低;然而,从淋巴瘤到肉瘤的肿瘤谱发生了显着变化,表明MSH3是p53驱动的肿瘤发生的有效调节剂。有趣的是,Msh3 -/-小鼠胚胎成纤维细胞在电离辐射后显示出增加的染色单体断裂和γH2AX病灶的持久性,表明DNA双链断裂修复存在缺陷。与Msh2 / p53肿瘤相比,Msh3 / p53肿瘤表现出杂合性丧失增加,全基因组拷贝数变异增加和中等的微卫星不稳定性表型,这表明MSH2-MSH3通过维持染色体稳定性来抑制肿瘤发生。我们的结果表明,由于MSH2-MSH3复合物在DNA双链断裂修复以及DNA错配修复中的作用,因此对于抑制晚期发作的肿瘤非常重要。此外,他们证明了MSH2-MSH3可抑制染色体不稳定性并在p53缺陷型肿瘤发生中调节肿瘤谱,并可能在其他染色体不稳定的肿瘤中发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号